ER-negative/HER2-positive DCIS showed the highest stromal density for all immune cell subsets except for CD3+CD8+ T-cell density, while ER-positive/HER2-negative DCIS showed lowest stromal immune cell densities (Supplementary Table 4). Here, ERBB2 is linked to ductal breast carcinoma in situ.